Home LiteratureArticle Details
PMID: 2905191 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Excitatory amino acid receptors intrinsic to synaptic transmission in nucleus tractus solitarii.

Brain research ·Vol. 456 ·No. 2 ·1988-07-26 ·Pages 333-43

Miller BD, Felder RB

Abstract

Excitatory amino acid (EAA) receptors are present in the nucleus tractus solitarii (NTS), and there is growing evidence that L-glutamate (L-Glu) may activate neurons in this region to precipitate changes in autonomic discharge. To evaluate the potential role of EAA agonists in synaptic transmission in NTS, we studied the responses of single units in an in vitro brain slice preparation of NTS to electrical stimulation of one or both solitary tracts (TS) before, during and after superfusion with selected EAA antagonists. Dose-response studies demonstrated that the synaptic input to NTS units was substantially blocked by 2-amino-5-phosphonovaleric acid (APV) at perfusion concentrations of 1 mM, by kynurenic acid (KYN) at 10 mM, and glutamate diethylester (GDEE) at 10 mM. Using these concentrations, we examined the responses of single NTS neurons to afferent input from ipsilateral and contralateral TS stimulation before, during and after perfusion with each antagonist. KYN inhibited afferent input from one TS but not the other in 7 of 13 cells tested, inhibited both inputs in 4, and caused differential augmentation of input in two. APV caused differential inhibition of the two inputs in 4 of 9 cells tested, differential excitation in 1 and inhibition of both inputs in one. GDEE caused differential inhibition in 4 of 9 cells tested, differential excitation in 3 and inhibition of both inputs in one. When inputs from a single TS were examined, those blocked by APV were always blocked by KYN (5 of 16 inputs tested); there was overlap between the blocking effects of KYN and GDEE (4 of 12 inputs tested) and occasionally of APV and GDEE (one of 12 inputs tested). We also observed differential blocking effects of these agents on single inputs to the same neuron. Evoked responses were reduced or enhanced by only one of the two agents for 5 of 16 inputs tested with KYN and APV, 4 of 12 tested with KYN and GDEE, and 7 of 12 tested with APV and GDEE. The average reduction in synaptically evoked responses caused by blocking doses of antagonist was 85 +/- 6% for KYN, 63 +/- 28% for APV and 68 +/- 10% for GDEE. These data indicate that all 3 major EAA antagonists can selectively inhibit electrically evoked afferent input to NTS neurons and suggest a role for specific EAA receptors in mediating input to these neurons over different afferent pathways.

MeSH Terms
2-Amino-5-phosphonovalerate Action Potentials Animals Electric Stimulation Functional Laterality Glutamates/pharmacology In Vitro Techniques Kynurenic Acid/pharmacology Male Medulla Oblongata/physiology Neurotransmitter Agents/antagonists & inhibitors Rats Rats, Inbred Strains Receptors, Amino Acid Receptors, Cell Surface/drug effects,physiology Reference Values Synapses/drug effects,physiology Synaptic Transmission/drug effects Valine/analogs & derivatives,pharmacology
Chemicals
Glutamates Neurotransmitter Agents Receptors, Amino Acid Receptors, Cell Surface glutamic acid diethyl ester 2-Amino-5-phosphonovalerate Kynurenic Acid Valine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Miller B D
Department of Internal Medicine, College of Medicine, University of Iowa, Iowa City 52242.
Felder R B
Article Info
Journal
Brain research
Abbr.
Brain Res
ISSN
0006-8993
Published
1988-07-26
Pages
333-43
Language
English
Region
Netherlands
NLM ID
0045503
Subset
IM
Grants
NHLBI NIH HHS · HL14388 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]